191 related articles for article (PubMed ID: 23681166)
21. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
22. Brain concentrations of d-MDMA are increased after stress.
Johnson EA; O'Callaghan JP; Miller DB
Psychopharmacology (Berl); 2004 May; 173(3-4):278-86. PubMed ID: 14735292
[TBL] [Abstract][Full Text] [Related]
23. Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver.
Cerretani D; Bello S; Cantatore S; Fiaschi AI; Montefrancesco G; Neri M; Pomara C; Riezzo I; Fiore C; Bonsignore A; Turillazzi E; Fineschi V
Pharmacol Res; 2011 Nov; 64(5):517-27. PubMed ID: 21864684
[TBL] [Abstract][Full Text] [Related]
24. RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").
Ricaurte GA; Yuan J; Hatzidimitriou G; Cord BJ; McCann UD
Science; 2002 Sep; 297(5590):2260-3. PubMed ID: 12351788
[TBL] [Abstract][Full Text] [Related]
25. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
26. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
Itzhak Y; Achat-Mendes CN; Ali SF; Anderson KL
Neuropharmacology; 2004 Jan; 46(1):74-84. PubMed ID: 14654099
[TBL] [Abstract][Full Text] [Related]
27. The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA.
Ruiz-Medina J; Ledent C; Carretón O; Valverde O
J Psychopharmacol; 2011 Apr; 25(4):550-64. PubMed ID: 21262860
[TBL] [Abstract][Full Text] [Related]
28. [The acute effects of 3,4-methylenedioxymethamphetamine on oxidative stress in rat brain].
Simić I; Malicević Z
Med Pregl; 2008; 61(5-6):222-5. PubMed ID: 19102066
[TBL] [Abstract][Full Text] [Related]
29. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.
Costa G; Morelli M; Simola N
Neurotox Res; 2017 Nov; 32(4):563-574. PubMed ID: 28597409
[TBL] [Abstract][Full Text] [Related]
30. Aged rats are more vulnerable than adolescents to "ecstasy"-induced toxicity.
Feio-Azevedo R; Costa VM; Barbosa DJ; Teixeira-Gomes A; Pita I; Gomes S; Pereira FC; Duarte-Araújo M; Duarte JA; Marques F; Fernandes E; Bastos ML; Carvalho F; Capela JP
Arch Toxicol; 2018 Jul; 92(7):2275-2295. PubMed ID: 29869127
[TBL] [Abstract][Full Text] [Related]
31. Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice.
Viñals X; Maldonado R; Robledo P
Addict Biol; 2013 Mar; 18(2):263-73. PubMed ID: 22260267
[TBL] [Abstract][Full Text] [Related]
32. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
33. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
Rizzo FR; Federici M; Mercuri NB
Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
[TBL] [Abstract][Full Text] [Related]
34. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
Frau L; Simola N; Porceddu PF; Morelli M
Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954
[TBL] [Abstract][Full Text] [Related]
35. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
36. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Seger D
Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
[TBL] [Abstract][Full Text] [Related]
37. Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice.
Daza-Losada M; Rodríguez-Arias M; Maldonado C; Aguilar MA; Miñarro J
Eur J Pharmacol; 2008 Aug; 590(1-3):204-11. PubMed ID: 18585379
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy).
Jayanthi S; Ladenheim B; Andrews AM; Cadet JL
Neuroscience; 1999; 91(4):1379-87. PubMed ID: 10391444
[TBL] [Abstract][Full Text] [Related]
39. d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity.
Johnson EA; Shvedova AA; Kisin E; O'Callaghan JP; Kommineni C; Miller DB
Brain Res; 2002 Apr; 933(2):150-63. PubMed ID: 11931860
[TBL] [Abstract][Full Text] [Related]
40. Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice.
Plaza-Zabala A; Viñals X; Maldonado R; Robledo P
Psychopharmacology (Berl); 2010 Mar; 208(4):563-73. PubMed ID: 20066403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
